Liaoning Aoda Pharmaceutical Co.,Ltd.is a subsidiary of BUCHANG PHARMA located in Yingkou City on the coast of the Bohai Sea, the company was founded in 1988 and adheres to the corporate philosophy of "Dedicated to the cause of medicine, committed to improving human health".
　　Covering a total area of 100,000 square meters with a construction area of 50,000 square meters, the company boasts GMP-compliant production lines for oral preparations (including tablets, capsules, granules and dry suspensions) as well as active pharmaceutical ingredients (APIs) and pharmaceutical excipients.Its annual production capacity reaches 400 million tablets, 200 million capsules, 100 million bags of granules & dry suspensions, and 8,000 tons of APIs & pharmaceutical excipients. The company holds over 60 national-level production approvals for its products.
　　Currently, Aoda Pharmaceutical has developed into a high-tech pharmaceutical enterprise.

　 　Mu Dan Granules is the world's first innovative drug for the treatment of diabetic neuropathy.
　　Diabetic neuropathy is one of the most prevalent and common complications of diabetes, causing extensive damage to the human body—virtually no tissue or organ from head to toe, from the superficial to the deep, is spared. It not only severely endangers patients' health, but also carries a risk of disability and even mortality, imposing a heavy burden on both patients and society. For a long time, there has been a lack of effective treatment options worldwide, making this condition a recognized international medical challenge.
　　In response to the severe threat posed by diabetic neuropathy, Liaoning Aoda Pharmaceutical successfully developed Mu Dan Granules after 11 years of intensive research and development. This medication provides a new and effective treatment option for patients with diabetes and a powerful therapeutic tool for clinicians, thus overcoming this long-standing global medical challenge.